New implant for addiction treatment put to the test in healthy volunteers
NCT ID NCT07269873
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study is testing a new implantable pellet (BICX104) that slowly releases naltrexone over 3 months. Researchers want to see how the body processes the drug and if it's safe, comparing it to a standard monthly naltrexone shot. The study involves 30 healthy adults and does not aim to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE AND FEMALE VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Study Site
RECRUITINGMiami, Florida, 33106, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can 10-Minute exercise snacks replace the gym marathon?
- Can a common ADHD drug truly sharpen a healthy mind? a trial puts it to the test
- Breathe deep: new study reveals how slow breathing calms your Body's nerves
- New Gene-Targeting shot shows promise for cholesterol control
- New drug ORX489 put to the test in healthy adults
- Exercise before surgery: could ReHIIT boost recovery for bowel cancer patients?